1. Home
  2. RVMD vs BNTX Comparison

RVMD vs BNTX Comparison

Compare RVMD & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Revolution Medicines Inc.

RVMD

Revolution Medicines Inc.

HOLD

Current Price

$203.94

Market Cap

30.1B

Sector

Health Care

ML Signal

HOLD

Logo BioNTech SE

BNTX

BioNTech SE

HOLD

Current Price

$97.10

Market Cap

24.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RVMD
BNTX
Founded
2014
2008
Country
United States
Germany
Employees
N/A
7807
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.1B
24.7B
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
RVMD
BNTX
Price
$203.94
$97.10
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
19
13
Target Price
$140.84
$133.46
AVG Volume (30 Days)
1.6M
1.5M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$533.02
$3.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$42.18
$79.81
52 Week High
$224.31
$124.00

Technical Indicators

Market Signals
Indicator
RVMD
BNTX
Relative Strength Index (RSI) 47.42 42.40
Support Level $198.91 $88.36
Resistance Level $222.33 $98.81
Average True Range (ATR) 8.08 3.37
MACD -1.85 -1.62
Stochastic Oscillator 15.73 0.55

Price Performance

Historical Comparison
RVMD
BNTX

About RVMD Revolution Medicines Inc.

Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: